Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
Biopharmaceutical company Immunic, Inc. has officially announced the appointment of Dr. Michael A. Panzara, M.D., M.P.H., who has extensive experience in the biopharmaceutical field, as Chief Medical Officer.

Biopharmaceutical company Immunic, Inc. has officially announced the appointment of Dr. Michael A. Panzara, M.D., M.P.H., who has extensive experience in the biopharmaceutical field, as Chief Medical Officer.

老虎证券老虎证券2026/04/28 10:38
Show original
Dr. Panzara has extensive credentials in drug research and clinical development, and this appointment will strengthen Immunic's leadership team in the field of innovative therapy development. Dr. Panzara has led multiple major clinical projects and achieved significant results in therapeutic areas such as neuroscience and immunology. His addition is expected to accelerate the clinical advancement of Immunic’s pipeline drugs and inject new professional perspectives into the company's strategic planning. This personnel change demonstrates Immunic's determination to continuously enhance its R&D capabilities and advance the global development of its candidate drugs. The company stated that Dr. Panzara’s industry experience and scientific insight will provide vital support for the development of innovative therapies for autoimmune and inflammatory diseases.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

European economic resilience exceeds expectations, ECB board member Kocher says higher interest rates are sustainable

Martin Kocher, a member of the Executive Board of the European Central Bank and Governor of the Austrian National Bank, stated in an interview that the resilience shown by the European economy has exceeded expectations.

智通财经2026/09/24 07:16
European economic resilience exceeds expectations, ECB board member Kocher says higher interest rates are sustainable

Reform remains unresolved, UBS downgrades Pacific Gas and Electric (PCG.US) rating to "Neutral"

UBS has downgraded California utility company Pacific Gas and Electric (PCG.US) from "Buy" to "Neutral," lowering the target price from $19 to $14.

智通财经2026/09/24 07:11